{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:44:42Z","timestamp":1776318282578,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11096-020-01220-z","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:20:18Z","timestamp":1610018418000},"page":"1082-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service"],"prefix":"10.1007","volume":"43","author":[{"given":"Seif","family":"El Hadidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kerins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtissam","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Bermingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1220_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC 2012 Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2012;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"1220_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ejhf.887","volume":"19","author":"M Komajda","year":"2017","unstructured":"Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS, et al. Physicians\u2019 guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2017;19:1414\u201323.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","volume":"38","author":"W Ouwerkerk","year":"2017","unstructured":"Ouwerkerk W, Voors AA, Anker SD, Cleland JG, Dickstein K, Filippatos G, et al. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study. Eur Heart J. 2017;38:1883\u201390.","journal-title":"Eur Heart J"},{"key":"1220_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72:351\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1220_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ejhf.1351","volume":"21","author":"CN Marti","year":"2019","unstructured":"Marti CN, Fonarow GC, Anker SD, Yancy C, Vaduganathan M, Greene SJ, et al. Medication dosing for heart failure with reduced ejection fraction: opportunities and challenges. Eur J Heart Fail. 2019;21:286\u201396.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/eurjhf\/hfr116","volume":"13","author":"UM Mogensen","year":"2011","unstructured":"Mogensen UM, Ersboll M, Andersen M, Andersson C, Hassager C, Torp-Pedersen C, et al. Clinical characteristics and major comorbidities in heart failure patients more than 85\u00a0years of age compared with younger age groups. Eur J Heart Fail. 2011;13:1216\u201323.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/ehf2.12347","volume":"5","author":"M Hassanein","year":"2018","unstructured":"Hassanein M, Abdelhamid M, Ibrahim B, Sobhy M, Nasr G, Aboleineen MW, et al. Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry. ESC Heart Fail. 2018;5:1159\u201364.","journal-title":"ESC Heart Fail"},{"issue":"15","key":"1220_CR9","doi-asserted-by":"publisher","first-page":"e008789","DOI":"10.1161\/JAHA.118.008789","volume":"7","author":"LG Gilstrap","year":"2018","unstructured":"Gilstrap LG, Stevenson LW, Small R, Parambi R, Hamershock R, Greenberg J, et al. Reasons for guideline non-adherence at heart failure discharge. J Am Heart Assoc. 2018;7(15):e008789.","journal-title":"J Am Heart Assoc"},{"key":"1220_CR10","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.ijcard.2012.06.116","volume":"167","author":"PR Kalra","year":"2013","unstructured":"Kalra PR, Morley C, Barnes S, Menown I, Kassianos G, Padmanabhan S, et al. Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study. Int J Cardiol. 2013;167:2695\u20139.","journal-title":"Int J Cardiol"},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.115.014281","volume":"132","author":"LA Allen","year":"2015","unstructured":"Allen LA, Fonarow GC, Liang L, Schulte PJ, Masoudi FA, Rumsfeld JS, et al. Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures. Circulation. 2015;132:1347\u201353.","journal-title":"Circulation"},{"key":"1220_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2165\/11591090-000000000-00000","volume":"28","author":"GE Caughey","year":"2011","unstructured":"Caughey GE, Roughead EE, Shakib S, Vitry AI, Gilbert AL. Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data. Drugs Aging. 2011;28:575\u201381.","journal-title":"Drugs Aging"},{"issue":"658","key":"1220_CR13","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.3399\/bjgp17X690533","volume":"67","author":"B Baron-Franco","year":"2017","unstructured":"Baron-Franco B, McLean G, Mair FS, Roger VL, Guthrie B, Mercer SW. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care. Br J Gen Pract. 2017;67(658):e314\u201320.","journal-title":"Br J Gen Pract"},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","volume":"134","author":"RL Page","year":"2016","unstructured":"Page RL, O\u2019Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134:e32\u201369.","journal-title":"Circulation"},{"key":"1220_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ejhf.132","volume":"16","author":"M Bermingham","year":"2014","unstructured":"Bermingham M, Ryder M, Travers B, Edwards N, Lalor L, Kelly D, et al. The St Vincent\u2019s potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care. Eur J Heart Fail. 2014;16:915\u201322.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40266-019-00645-0","volume":"36","author":"GE Caughey","year":"2019","unstructured":"Caughey GE, Shakib S, Barratt JD, Roughead EE. Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity. Drugs Aging. 2019;36:471\u20139.","journal-title":"Drugs Aging"},{"key":"1220_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehi251","volume":"26","author":"M Komajda","year":"2005","unstructured":"Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26:1653\u20139.","journal-title":"Eur Heart J"},{"key":"1220_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.ejheart.2008.09.008","volume":"10","author":"S Stork","year":"2008","unstructured":"Stork S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, et al. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail. 2008;10:1236\u201345.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejim.2015.12.007","volume":"29","author":"A Deticek","year":"2016","unstructured":"Deticek A, Locatelli I, Roblek T, Mrhar A, Lainscak M. Therapy modifications during hospitalization in patients with chronic heart failure. Eur J Int Med. 2016;29:52\u20138.","journal-title":"Eur J Int Med"},{"key":"1220_CR20","unstructured":"Health Products Regulatory Authority. Summary of Product Characteristics. Dublin, Ireland. https:\/\/www.hpra.ie\/homepage\/medicines\/medicines-information\/find-a-medicine\/results. Accessed 28 Aug 2020."},{"key":"1220_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00392-007-0617-6","volume":"97","author":"F Peters-Klimm","year":"2008","unstructured":"Peters-Klimm F, Muller-Tasch T, Schellberg D, Remppis A, Barth A, Holzapfel N, et al. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol. 2008;97:244\u201352.","journal-title":"Clin Res Cardiol"},{"key":"1220_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00392-015-0939-8","volume":"105","author":"MN Hirt","year":"2016","unstructured":"Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T. General practitioners\u2019 adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol. 2016;105:441\u201350.","journal-title":"Clin Res Cardiol"},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ejhpharm-2015-000762","volume":"23","author":"NL Barnett","year":"2016","unstructured":"Barnett NL, Oboh L, Smith K. Patient-centred management of polypharmacy: a process for practice. Eur J Hosp Pharm. 2016;23:113\u20137.","journal-title":"Eur J Hosp Pharm"},{"key":"1220_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/pds.4430","volume":"27","author":"S El Hadidi","year":"2018","unstructured":"El Hadidi S, Darweesh E, Byrne S, Bermingham M. A tool for assessment of heart failure prescribing quality: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2018;27:685\u201394.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2014.04.255","volume":"175","author":"G Poelzl","year":"2014","unstructured":"Poelzl G, Altenberger J, Pacher R, Ebner CH, Wieser M, Winter A, et al. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. Int J Cardiol. 2014;175:83\u20139.","journal-title":"Int J Cardiol"},{"key":"1220_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/eurjhf\/hfq047","volume":"12","author":"L Frankenstein","year":"2010","unstructured":"Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, et al. The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail. 2010;12:574\u201380.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1220_CR27","first-page":"e37","volume":"19","author":"M Oertle","year":"2010","unstructured":"Oertle M, Bal R. Understanding non-adherence in chronic heart failure: a mixed-method case study. Qual Saf Health Care. 2010;19(6):e37.","journal-title":"Qual Saf Health Care"},{"key":"1220_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/ejhf.1182","volume":"20","author":"G Savarese","year":"2018","unstructured":"Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlstrom U, et al. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018;20:1326\u201334.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/ejhf.900","volume":"19","author":"JP Ferreira","year":"2017","unstructured":"Ferreira JP, Rossignol P, Machu JL, Sharma A, Girerd N, Anker SD, et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017;19:1284\u201393.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309\u201321.","journal-title":"N Engl J Med"},{"key":"1220_CR31","unstructured":"Health Service Executive Medicines Management Programme Preferred Drugs. Beta-adrenoreceptor blocking drugs for the treatment of heart-failure, angina and hypertension. https:\/\/www.hse.ie\/eng\/services\/publications\/clinical-strategy-and-programmes\/beta-blockers.pdf. Accessed 28 Aug 2020."},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jchf.2015.09.002","volume":"4","author":"M Fiuzat","year":"2016","unstructured":"Fiuzat M, Wojdyla D, Pina I, Adams K, Whellan D, O\u2019Connor CM. Heart rate or beta-blocker dose? Association with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION trial. JACC Heart Fail. 2016;4:109\u201315.","journal-title":"JACC Heart Fail"},{"key":"1220_CR33","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100:2312\u20138.","journal-title":"Circulation"},{"key":"1220_CR34","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","volume":"374","author":"MA Konstam","year":"2009","unstructured":"Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet. 2009;374:1840\u20138.","journal-title":"Lancet"},{"key":"1220_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jchf.2018.11.011","volume":"7","author":"PA Peri-Okonny","year":"2019","unstructured":"Peri-Okonny PA, Mi X, Khariton Y, Patel KK, Thomas L, Fonarow GC, et al. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry. JACC Heart Fail. 2019;7:350\u20138.","journal-title":"JACC Heart Fail"},{"key":"1220_CR36","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.jacc.2017.03.563","volume":"69","author":"AS Bhatt","year":"2017","unstructured":"Bhatt AS, DeVore AD, DeWald TA, Swedberg K, Mentz RJ. Achieving a maximally tolerated beta-blocker dose in heart failure patients: is there room for improvement? J Am Coll Cardiol. 2017;69:2542\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1220_CR37","unstructured":"Health Service Executive Primary Care Reimbursement Service. Circular No. 52\/17 Reimbursement of Sacubitril\/Valsartan (Entresto) effective 1st December 2017. Dublin, Ireland. 2017. https:\/\/www.hse.ie\/eng\/staff\/pcrs\/circulars\/pharmacy\/052-2017-pharmacy-circular-reimbursement-of-entresto.pdf. Accessed 28 Aug 2020."},{"key":"1220_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ejheart.2003.08.003","volume":"6","author":"M Ledwidge","year":"2004","unstructured":"Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail. 2004;6:235\u201343.","journal-title":"Eur J Heart Fail"},{"key":"1220_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00392-014-0678-2","volume":"103","author":"U Tebbe","year":"2014","unstructured":"Tebbe U, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, et al. Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol. 2014;103:665\u201373.","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"1220_CR40","doi-asserted-by":"publisher","first-page":"e003866","DOI":"10.1136\/bmjopen-2013-003866","volume":"4","author":"HC Hancock","year":"2014","unstructured":"Hancock HC, Close H, Fuat A, Murphy JJ, Hungin AP, Mason JM. Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10\u00a0years: a qualitative study and national survey. BMJ Open. 2014;4(3):e003866.","journal-title":"BMJ Open"},{"key":"1220_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/MLR.0b013e3182a3e525","volume":"51","author":"MA Steinman","year":"2013","unstructured":"Steinman MA, Dimaano L, Peterson CA, Heidenreich PA, Knight SJ, Fung KZ, et al. Reasons for not prescribing guideline-recommended medications to adults with heart failure. Med Care. 2013;51:901\u20137.","journal-title":"Med Care"},{"key":"1220_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.amjcard.2008.11.058","volume":"103","author":"M Mockler","year":"2009","unstructured":"Mockler M, O\u2019Loughlin C, Murphy N, Ryder M, Conlon C, McDonald KM, et al. Causes and consequences of nonpersistence with heart failure medication. Am J Cardiol. 2009;103:834\u20138.","journal-title":"Am J Cardiol"},{"key":"1220_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1130-6343(06)74004-1","volume":"30","author":"C Lopez Cabezas","year":"2006","unstructured":"Lopez Cabezas C, Falces Salvador C, Cubi Quadrada D, Arnau Bartes A, Ylla Bore M, Muro Perea N, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp. 2006;30:328\u201342.","journal-title":"Farm Hosp"},{"key":"1220_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/eurheartj\/ehr433","volume":"33","author":"R Lowrie","year":"2012","unstructured":"Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012;33:314\u201324.","journal-title":"Eur Heart J"},{"key":"1220_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/1060028018760568","volume":"52","author":"S Bhat","year":"2018","unstructured":"Bhat S, Kansal M, Kondos GT, Groo V. Outcomes of a pharmacist-managed heart failure medication titration assistance clinic. Ann Pharmacother. 2018;52:724\u201332.","journal-title":"Ann Pharmacother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01220-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:27:48Z","timestamp":1628537268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01220-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01220-z","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}